Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member
News
The Leukemia & Lymphoma Society Launches First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
The global leader in the fight against blood cancers, The Leukemia & Lymphoma Society (LLS), announced the launch of its Pediatric Acute Leukemia (Ped…
News
LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
LLS Remains Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling
Patient Education Webcasts
Addressing the Financial Impact of Cancer
News
America’s Youngest Generation is Trailblazing the Way for a Future without Cancer
The Leukemia & Lymphoma Society Announces Winners of 2022 National Students of the Year Philanthropic Competition …
Patient Education Webcasts
Caregiving Over Coffee: An Interactive Q&A with Dr. Mitchell
Research
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline
Marseille, France, June 13, 2022 – ImCheck Therapeutics announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird…
Legal Advocacy
LLS engages the court system and government oversight authorities to secure and maintain critical protections for patients with conditions like blood …
News
FDA Approves Immunotherapy for Aggressive Form of Follicular Lymphoma
The U.S. Food and Drug Administration (FDA) has approved CAR T-immunotherapy tisagenlecleucel (Kymriah®) for patients with follicular lymphoma (FL) wh…
News
FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid Leukemia
The Food and Drug Administration (FDA) recently approved a combination of the targeted therapy ivosidenib (Tibsovo) and the chemotherapy azacitidine f…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
